ABSTRACT The effect of a single dose of diazepam on sleep and respiration was studied in nine patients with chronic airflow obstruction with moderate arterial hypoxaemia but no hypercapnia. Diazepam improved sleep duration without exacerbating nocturnal hypoxaemia and there was no change in the number of apnoeic events after a single 5 mg dose at night.
Diazepam has been advocated as a treatment for breathlessness in patients with chronic airflow obstruction.' Previous studies have suggested that the benzodiazepine hypnotic flurazepam can cause sleep disordered breathing, with nocturnal oxygen desaturation, an increased frequency of apnoeic episodes and reduced rapid eye movement (REM) sleep. 24 The effects of diazepam on respiration at night have not, however, been evaluated.
We have therefore performed a double blind, placebo controlled study to investigate the effects and safety ofa small nocturnal dose of diazepam on sleep quality and respiration at night in patients with chronic airflow obstruction and moderate arterial hypoxaemia.
Methods
We studied nine patients (eight of them men) in the sleep laboratory (mean age 67-6 (SD 6-18) years and weight 62-8 (17 5) kg) with stable chronic airflow obstruction (mean FEVy 1-13 (047) 1 and FVC 2-38 (086) 1) and moderate arterial hypoxaemia (mean arterial oxygen tension (Pao2) 9 05 (0-73) kPa) but no hypercapnia (mean arterial carbon dioxide tension (Paco2) 4 97 (0 40) kPa).
After an initial accimatisation night in the sleep laboratory, the subjects were studied on two further nights, between 2200 and 0700 h, at least five days apart. In this study a single dose of diazepam 5 mg did not increase the risk ofsleep disordered breathing in patients with chronic airflow obstruction. Diazepam may be useful in relieving dyspnoea and anxiety in these patients,' but further studies are required to assess its safety at night after repeated dosage. 
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